The first canine influenza vaccine is now fully licensed by the USDA

Intervet/Schering-Plough Animal Health is please to announce that Canine Influenza Vaccine, H3N8 has been granted a full license by the USDA after a year of safe and effective use in half a million dogs. Now called Nobivac(R) Canine Flu H3N8, the vaccine has been proven to reduce the severity and spread of disease.

Join the global fight against canine rabies.

For every dose of Continuum® canine or feline vaccine, Nobivac™ Lyme, or Canine Influenza Vaccine, H3N8* sold in the US, Intervet/Schering-Plough Animal Health will donate a dose of rabies vaccine to save dogs and families in the Serengeti.

Find out how you can get involved.

A trusted source for comprehensive animal health

Intervet/Schering-Plough Animal Health is a global, research-driven company that develops, manufactures and markets abroad range of veterinary medicines and services. We offer one of the industry’s most innovative portfolios, spanning products for the prevention, treatment and control of disease in all major farm and companion animal species.

News & Media

Merck & Co., Inc.

Joint Venture Updates

Intervet Inc.